These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 24841868)

  • 1. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
    Wu X; Lin H; Li S
    BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
    Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.
    Orsini RG; Verhoeven RH; Lemmens VE; van Steenbergen LN; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
    Eur J Cancer; 2015 Sep; 51(13):1675-82. PubMed ID: 26159248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
    World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
    Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
    Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.
    Winer J; Zenati M; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2014 May; 21(5):1456-62. PubMed ID: 24201745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.
    Pozos-Ochoa LI; Lino-Silva LS; León-Takahashi AM; Salcedo-Hernández RA
    Pathol Oncol Res; 2018 Jul; 24(3):609-616. PubMed ID: 28785968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
    Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
    J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Features and Survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, Left Colon, and Rectum.
    Zhu L; Ling C; Xu T; Zhang J; Zhang Y; Liu Y; Fang C; Yang L; Zhuang W; Wang R; Ping J; Wang M
    Pathol Oncol Res; 2021; 27():1609800. PubMed ID: 34276258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma.
    Hugen N; Verhoeven RH; Radema SA; de Hingh IH; Pruijt JF; Nagtegaal ID; Lemmens VE; de Wilt JH
    Ann Oncol; 2013 Nov; 24(11):2819-24. PubMed ID: 24057984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.
    Tung SY; Wu CS; Chen PC
    Am J Gastroenterol; 1996 Oct; 91(10):2195-9. PubMed ID: 8855747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
    Korphaisarn K; Morris V; Davis JS; Overman MJ; Fogelman DR; Kee BK; Dasari A; Raghav KPS; Shureiqi I; Trupti M; Wolff RA; Eng C; Menter DG; Hamilton S; Kopetz S
    Br J Cancer; 2019 Sep; 121(6):505-510. PubMed ID: 31406299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
    Qiu MZ; Teng KY; Ruan DY; Li YH; Chen XQ; Pan ZZ; He YJ; Wan DS; Xu RH
    Ai Zheng; 2009 Jul; 28(7):743-8. PubMed ID: 19624903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
    Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
    Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma.
    Zhao Z; Yan N; Pan S; Wang DW; Li ZW
    Sci Rep; 2020 Aug; 10(1):14126. PubMed ID: 32839528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
    J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.
    Park HS; Jung M; Kim HS; Kim HI; An JY; Cheong JH; Hyung WJ; Noh SH; Kim YI; Chung HC; Rha SY
    Ann Surg Oncol; 2015 Jan; 22(1):224-31. PubMed ID: 25081339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer.
    Sheng H; Wei X; Mao M; He J; Luo T; Lu S; Zhou L; Huang Z; Yang A
    BMC Cancer; 2019 Nov; 19(1):1071. PubMed ID: 31703713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.